Headlines for ING GROUP N V http://www.rssboard.org/rss-specification Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-08/bad-news-for-viropharma-analyst-blog.aspx.aspx?storyid=161351&source=itxwebtxt0000015 Nasdaq Fri, 03 Aug 2012 18:14:01 GMT http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-07/positive-data-on-alnylam-candidate-analyst-blog.aspx.aspx?storyid=157945&source=itxwebtxt0000015 Nasdaq Mon, 23 Jul 2012 17:09:37 GMT http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-07/midday-update-markets-rise-on-corporate-earnings-bargain-hunting.aspx.aspx?storyid=157105&source=itxwebtxt0000015 Nasdaq Thu, 19 Jul 2012 12:13:00 GMT http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-07/cubist-initiates-patient-enrolment-analyst-blog.aspx.aspx?storyid=155690&source=itxwebtxt0000015 Nasdaq Fri, 13 Jul 2012 15:47:11 GMT http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-06/orphan-status-for-alnylam-drug-analyst-blog.aspx.aspx?storyid=150137&source=itxwebtxt0000015 Nasdaq Thu, 21 Jun 2012 10:45:01 GMT http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-06/get-to-know-addex-therapeutics-initiating-coverage-analyst-blog.aspx.aspx?storyid=149787&source=itxwebtxt0000015 Nasdaq Wed, 20 Jun 2012 11:29:01 GMT http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-06/cubist-discusses-strategic-goals-analyst-blog.aspx.aspx?storyid=147900&source=itxwebtxt0000015 Nasdaq Tue, 12 Jun 2012 17:48:01 GMT http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-05/q1-10q-development-ontrack-analyst-blog.aspx.aspx?storyid=142022&source=itxwebtxt0000015 Nasdaq Thu, 17 May 2012 10:16:01 GMT http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-04/the-myth-of-expert-advice-part-1.aspx.aspx?storyid=133392&source=itxwebtxt0000015 Nasdaq Thu, 12 Apr 2012 10:38:58 GMT http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-02/alnylam-delivers-inline-numbers-analyst-blog.aspx.aspx?storyid=120340&source=itxwebtxt0000015 Nasdaq Mon, 13 Feb 2012 09:00:01 GMT http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-01/alnylam-to-cut-33-jobs-analyst-blog.aspx.aspx?storyid=115909&source=itxwebtxt0000015 Nasdaq Mon, 23 Jan 2012 11:15:01 GMT http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-01/alnylam-down-to-neutral-analyst-blog.aspx.aspx?storyid=115648&source=itxwebtxt0000015 Nasdaq Fri, 20 Jan 2012 15:00:01 GMT http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2011-12/alnylam-states-preclinical-data-analyst-blog.aspx.aspx?storyid=111759&source=itxwebtxt0000015 Nasdaq Fri, 30 Dec 2011 15:00:01 GMT http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2011-12/still-bullish-on-alnylam-analyst-blog.aspx.aspx?storyid=107358&source=itxwebtxt0000015 Nasdaq Wed, 07 Dec 2011 11:00:01 GMT http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2011-11/alnylam-reveals-alnttr01-trial-data-analyst-blog.aspx.aspx?storyid=104992&source=itxwebtxt0000015 Nasdaq Fri, 25 Nov 2011 13:00:01 GMT